Insider Trading Alert - ACHC, ARO And ICPT Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 27, 2014, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $66.82 to $18,231,262.91.

Highlighted Stocks Traded by Insiders:

Acadia Healthcare (ACHC) - FREE Research Report

Grieco William, who is Director at Acadia Healthcare, sold 4,522 shares at $50.67 on Aug. 27, 2014. Following this transaction, the Director owned 29,762 shares meaning that the stake was reduced by 13.19% with the 4,522-share transaction.

The shares most recently traded at $51.17, up $0.50, or 0.98% since the insider transaction. Historical insider transactions for Acadia Healthcare go as follows:

  • 4-Week # shares sold: 10,889
  • 12-Week # shares sold: 10,889
  • 24-Week # shares sold: 94,242

The average volume for Acadia Healthcare has been 476,800 shares per day over the past 30 days. Acadia Healthcare has a market cap of $3.1 billion and is part of the health care sector and health services industry. Shares are up 9.82% year-to-date as of the close of trading on Wednesday.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, and substance abuse facilities in the United States. The company has a P/E ratio of 42.0. Currently, there are 7 analysts who rate Acadia Healthcare a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACHC - FREE

TheStreet Quant Ratings rates Acadia Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Acadia Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

5 Earnings Short-Squeeze Plays: Twitter, Sarepta Therapeutics Included

Obamacare Repeal Takes Another Step but GOP Showdown Looms

Health Care Investors Attempt to Parse Trump Budget

Finding the Bullish and Bearish Reversals

Leveling the Playing Field for Investors: Cramer's 'Mad Money' Recap (Friday 2/3/17)